Trial Protocol ID USOR 20298_VS-6766-201 GOG 3052 *STAR*

Trial Description

A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Contact us regarding Clinical Trials at or call us at 877-664-7724


  • Carol Tweed, M.D.

Disease Types


  • GOG Foundation Verastem Inc. NCT ID

  • NCT04625270